RecruitingNot ApplicableNCT07044973

VIM+PTT MRgFUS for PD

Dual-Target MR-guided Focused Ultrasound for Parkinson Disease


Sponsor

Chinese PLA General Hospital

Enrollment

20 participants

Start Date

Jul 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this prospective, single-arm, open-label study is to assess the safety and efficacy of the staged, dual-target(VIM+PTT thalamotomy)to treat Patiensts with Parkinson Disease using transcranial magnetic resonance guided focused ultrasound system ExAblate 4000, InSightec Ltd.


Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a focused ultrasound brain procedure for Parkinson's disease that targets two areas simultaneously — the VIM (a movement-control area) and another pathway (PTT). The procedure uses MRI-guided focused ultrasound waves to create a tiny, precise area of treatment in the brain without surgery, aiming to reduce tremor and other Parkinson's symptoms. **You may be eligible if...** - You have a diagnosis of Parkinson's disease - You have significant tremor or motor symptoms not well controlled by medication - You are a candidate for focused ultrasound based on brain imaging - You are able to undergo MRI **You may NOT be eligible if...** - You have metal implants in your head that are incompatible with MRI - You have had prior brain surgery or deep brain stimulation - You have significant cognitive impairment or other neurological conditions - You have uncontrolled medical conditions - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURETranscranial focused ultrasound thalamotomy

Thalamotomy Using Exblate


Locations(1)

Chinese PLA General Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07044973


Related Trials